{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:31:13Z","timestamp":1783474273167,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Understanding how preexisting comorbidities may interact with a critical illness is important for the assessment of long-term survival probability of older patients admitted to the ICU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>The mortality after a first ICU admission in patients\u2009\u2265\u200955\u00a0years old registered in the Swedish Intensive Care Registry was compared to age- and sex-matched individuals from the general population with a landmark after 1 year. The comparison was adjusted for age, sex, and baseline comorbidity using Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 7-year study period included 140 008 patients, of whom 23% were 80 years or older. Patients surviving the first year remained at an increased risk compared to the general population, but much of this difference was attenuated after adjustment for baseline comorbidity (HR, 1.03; 95% CI 1.02\u20131.04). Excluding cardio-thoracic ICU admissions, the increased risk remained slightly elevated (adjusted HR, 1.15; 95% CI 1.13\u20131.16). Also, the subgroup\u2009\u2265\u200975\u00a0years old surviving the first year returned to a mortality rate comparable to the general population (HR, 0.98; 95% CI 0.96\u20130.99). Stratified by admission diagnosis an increased mortality rate remained beyond the first year for acute-on-chronic respiratory failure (adjusted HR, 1.47; 95% CI 1.36\u20131.58) but not for other respiratory causes (adjusted HR, 1.03; 95% CI 0.99\u20131.07) or admission for septic shock (adjusted HR, 1.04; 95% CI 0.95\u20131.13). No substantial increased mortality rate was notable beyond the first year for other admission diagnoses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Older ICU patients that survive the first year after an ICU admission return to a mortality rate close to that of the general population having similar baseline comorbidity, but variability is seen depending on the ICU admission diagnosis.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      ClinicalTrials.gov ID: NCT06234709, date 02\/01\/2024.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-024-05147-z","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:10:47Z","timestamp":1731586247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The long-term conditional mortality rate in older ICU patients compared to the general population"],"prefix":"10.1186","volume":"28","clinical-trial-number":[{"clinical-trial-number":"nct06234709","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0645-5853","authenticated-orcid":false,"given":"Anna","family":"Aronsson Dannewitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodil","family":"Svennblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Micha\u00eblsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miklos","family":"Lipcsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Gedeborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"5147_CR1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1183\/09031936.00059814","volume":"44","author":"MJ Divo","year":"2014","unstructured":"Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44:1055\u201368. https:\/\/doi.org\/10.1183\/09031936.00059814.","journal-title":"Eur Respir J"},{"key":"5147_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13054-016-1248-y","volume":"20","author":"AD Hill","year":"2016","unstructured":"Hill AD, Fowler RA, Pinto R, et al. Long-term outcomes and healthcare utilization following critical illness\u2014a population-based study. Crit Care. 2016;20:76. https:\/\/doi.org\/10.1186\/s13054-016-1248-y.","journal-title":"Crit Care"},{"key":"5147_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jcrc.2009.09.001","volume":"25","author":"Y Yang","year":"2010","unstructured":"Yang Y, Yang KS, Hsann YM, et al. The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis. J Crit Care. 2010;25:398\u2013405. https:\/\/doi.org\/10.1016\/j.jcrc.2009.09.001.","journal-title":"J Crit Care"},{"key":"5147_CR4","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1097\/CCM.0000000000006315","volume":"52","author":"A Perrella","year":"2024","unstructured":"Perrella A, Geen O, Ahuja M, et al. Exploring the impact of age, frailty, and multimorbidity on the effect of ICU interventions: a systematic review of randomized controlled trials. Crit Care Med. 2024;52:e463\u201372. https:\/\/doi.org\/10.1097\/CCM.0000000000006315.","journal-title":"Crit Care Med"},{"key":"5147_CR5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jama.2017.13889","volume":"318","author":"B Guidet","year":"2017","unstructured":"Guidet B, Leblanc G, Simon T, et al. Effect of systematic intensive care unit triage on long-term mortality among critically ill elderly patients in France: a randomized clinical trial. JAMA. 2017;318:1450. https:\/\/doi.org\/10.1001\/jama.2017.13889.","journal-title":"JAMA"},{"key":"5147_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252771","volume":"16","author":"EN van der Zee","year":"2021","unstructured":"van der Zee EN, Noordhuis LM, Epker JL, et al. Assessment of mortality and performance status in critically ill cancer patients: a retrospective cohort study. PLoS ONE. 2021;16: e0252771. https:\/\/doi.org\/10.1371\/journal.pone.0252771.","journal-title":"PLoS ONE"},{"key":"5147_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13054-022-04172-0","volume":"26","author":"A Aronsson Dannewitz","year":"2022","unstructured":"Aronsson Dannewitz A, Svennblad B, Micha\u00eblsson K, et al. Optimized diagnosis-based comorbidity measures for all-cause mortality prediction in a national population-based ICU population. Crit Care. 2022;26:306. https:\/\/doi.org\/10.1186\/s13054-022-04172-0.","journal-title":"Crit Care"},{"key":"5147_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/JETS.JETS_62_16","volume":"10","author":"D Kirshenbom","year":"2017","unstructured":"Kirshenbom D, Ben-Zaken Z, Albilya N, et al. Older age, comorbid illnesses, and injury severity affect immediate outcome in elderly trauma patients. J Emerg Trauma Shock. 2017;10:146\u201350. https:\/\/doi.org\/10.4103\/JETS.JETS_62_16.","journal-title":"J Emerg Trauma Shock"},{"key":"5147_CR9","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S20247","author":"JM Christensen","year":"2011","unstructured":"Christensen JM, Christiansen C, et al. Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive care. Clin Epidemiol. 2011. https:\/\/doi.org\/10.2147\/CLEP.S20247.","journal-title":"Clin Epidemiol"},{"key":"5147_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","volume":"47","author":"C van Walraven","year":"2009","unstructured":"van Walraven C, Austin PC, Jennings A, et al. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47:626\u201333. https:\/\/doi.org\/10.1097\/MLR.0b013e31819432e5.","journal-title":"Med Care"},{"key":"5147_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8\u201327. https:\/\/doi.org\/10.1097\/00005650-199801000-00004.","journal-title":"Med Care"},{"key":"5147_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5792","volume":"33","author":"VA Kiri","year":"2024","unstructured":"Kiri VA, -Tepie MF,. Comorbidity influence in observational studies: Why ignore the real world? Pharmacoepidemiology and Drug. 2024;33: e5792. https:\/\/doi.org\/10.1002\/pds.5792.","journal-title":"Pharmacoepidemiology and Drug"},{"key":"5147_CR13","unstructured":"The Swedish Intensive Care Registry (SIR) https:\/\/www.icuregswe.org\/en\/."},{"key":"5147_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450. https:\/\/doi.org\/10.1186\/1471-2458-11-450.","journal-title":"BMC Public Health"},{"key":"5147_CR15","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","volume":"32","author":"HL Brooke","year":"2017","unstructured":"Brooke HL, Talb\u00e4ck M, H\u00f6rnblad J, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32:765\u201373. https:\/\/doi.org\/10.1007\/s10654-017-0316-1.","journal-title":"Eur J Epidemiol"},{"key":"5147_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","volume":"24","author":"JF Ludvigsson","year":"2009","unstructured":"Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24:659\u201367. https:\/\/doi.org\/10.1007\/s10654-009-9350-y.","journal-title":"Eur J Epidemiol"},{"key":"5147_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-x","volume":"17","author":"M Schemper","year":"1996","unstructured":"Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17:343\u20136. https:\/\/doi.org\/10.1016\/0197-2456(96)00075-x.","journal-title":"Control Clin Trials"},{"key":"5147_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1200\/JCO.1991.9.1.191","volume":"9","author":"JJ Shuster","year":"1991","unstructured":"Shuster JJ. Median follow-up in clinical trials. J Clin Oncol. 1991;9:191\u20132. https:\/\/doi.org\/10.1200\/JCO.1991.9.1.191.","journal-title":"J Clin Oncol"},{"key":"5147_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1046\/j.1365-2044.2003.03205.x","volume":"58","author":"JC Wright","year":"2003","unstructured":"Wright JC, Plenderleith L, Ridley SA. Long-term survival following intensive care: subgroup analysis and comparison with the general population. Anaesthesia. 2003;58:637\u201342. https:\/\/doi.org\/10.1046\/j.1365-2044.2003.03205.x.","journal-title":"Anaesthesia"},{"key":"5147_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13613-024-01246-w","volume":"14","author":"DW de Lange","year":"2024","unstructured":"de Lange DW, Soliman IW, Leaver S, et al. The association of premorbid conditions with 6-month mortality in acutely admitted ICU patients over 80 years. Ann Intensive Care. 2024;14:46. https:\/\/doi.org\/10.1186\/s13613-024-01246-w.","journal-title":"Ann Intensive Care"},{"key":"5147_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0296804","volume":"19","author":"M Westerberg","year":"2024","unstructured":"Westerberg M, Irenaeus S, Garmo H, et al. Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study. PLoS ONE. 2024;19: e0296804. https:\/\/doi.org\/10.1371\/journal.pone.0296804.","journal-title":"PLoS ONE"},{"key":"5147_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111504","volume":"174","author":"M Westerberg","year":"2024","unstructured":"Westerberg M, Garmo H, Robinson D, et al. Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial. J Clin Epidemiol. 2024;174: 111504. https:\/\/doi.org\/10.1016\/j.jclinepi.2024.111504.","journal-title":"J Clin Epidemiol"},{"key":"5147_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/EDE.0000000000001358","volume":"32","author":"R Gedeborg","year":"2021","unstructured":"Gedeborg R, Sund M, Lambe M, et al. An aggregated comorbidity measure based on history of filled drug prescriptions: development and evaluation in two separate cohorts. Epidemiology. 2021;32:607\u201315. https:\/\/doi.org\/10.1097\/EDE.0000000000001358.","journal-title":"Epidemiology"},{"key":"5147_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241439","volume":"15","author":"R Gedeborg","year":"2020","unstructured":"Gedeborg R, Garmo H, Robinson D, Stattin P. Prescription-based prediction of baseline mortality risk among older men. PLoS ONE. 2020;15: e0241439. https:\/\/doi.org\/10.1371\/journal.pone.0241439.","journal-title":"PLoS ONE"},{"key":"5147_CR25","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1007\/s00134-024-07404-9","volume":"50","author":"J Muscedere","year":"2024","unstructured":"Muscedere J, Bagshaw SM, Kho M, et al. Frailty, outcomes, recovery and care steps of critically Ill patients (FORECAST): a prospective, multi-centre, cohort study. Intensive Care Med. 2024;50:1064\u201374. https:\/\/doi.org\/10.1007\/s00134-024-07404-9.","journal-title":"Intensive Care Med"},{"key":"5147_CR26","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1213\/ANE.0000000000004665","volume":"130","author":"JC De Biasio","year":"2020","unstructured":"De Biasio JC, Mittel AM, Mueller AL, et al. Frailty in critical care medicine: a review. Anesth Analg. 2020;130:1462\u201373. https:\/\/doi.org\/10.1213\/ANE.0000000000004665.","journal-title":"Anesth Analg"},{"key":"5147_CR27","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1007\/s00134-005-2762-6","volume":"31","author":"PGH Metnitz","year":"2005","unstructured":"Metnitz PGH, Moreno RP, Almeida E, et al. SAPS 3\u2014from evaluation of the patient to evaluation of the intensive care unit. Part 1: objectives, methods and cohort description. Intensive Care Med. 2005;31:1336\u201344. https:\/\/doi.org\/10.1007\/s00134-005-2762-6.","journal-title":"Intensive Care Med"},{"key":"5147_CR28","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0003-4975(97)00553-5","volume":"64","author":"TL Higgins","year":"1997","unstructured":"Higgins TL, Estafanous FG, Loop FD, et al. ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting. Ann Thorac Surg. 1997;64:1050\u20138. https:\/\/doi.org\/10.1016\/S0003-4975(97)00553-5.","journal-title":"Ann Thorac Surg"},{"key":"5147_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejcts.2010.01.053","volume":"38","author":"K Hekmat","year":"2010","unstructured":"Hekmat K, Doerr F, Kroener A, et al. Prediction of mortality in intensive care unit cardiac surgical patients. Eur J Cardiothorac Surg. 2010;38:104\u20139. https:\/\/doi.org\/10.1016\/j.ejcts.2010.01.053.","journal-title":"Eur J Cardiothorac Surg"},{"key":"5147_CR30","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","volume":"43","author":"S Halvorsen","year":"2022","unstructured":"Halvorsen S, Mehilli J, Cassese S, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022;43:3826\u2013924. https:\/\/doi.org\/10.1093\/eurheartj\/ehac270.","journal-title":"Eur Heart J"},{"key":"5147_CR31","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.jacc.2021.02.013","volume":"77","author":"M Hammond-Haley","year":"2021","unstructured":"Hammond-Haley M, Hartley A, Essa M, et al. Trends in ischemic heart disease and cerebrovascular disease mortality in Europe: an observational study 1990\u20132017. J Am Coll Cardiol. 2021;77:1697\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.013.","journal-title":"J Am Coll Cardiol"},{"key":"5147_CR32","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S0140-6736(13)62070-X","volume":"383","author":"S-C Chung","year":"2014","unstructured":"Chung S-C, Gedeborg R, Nicholas O, et al. Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK. Lancet. 2014;383:1305\u201312. https:\/\/doi.org\/10.1016\/S0140-6736(13)62070-X.","journal-title":"Lancet"},{"key":"5147_CR33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/intqhc\/mzu064","volume":"26","author":"H Quan","year":"2014","unstructured":"Quan H, Moskal L, Forster AJ, et al. International variation in the definition of \u2018main condition\u2019 in ICD-coded health data: Table 1. Int J Qual Health Care. 2014;26:511\u20135. https:\/\/doi.org\/10.1093\/intqhc\/mzu064.","journal-title":"Int J Qual Health Care"},{"key":"5147_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/TA.0b013e3182a9cd31","volume":"76","author":"R Gedeborg","year":"2014","unstructured":"Gedeborg R, Warner M, Chen L-H, et al. Internationally comparable diagnosis-specific survival probabilities for calculation of the ICD-10\u2013based Injury severity score. J Trauma Acute Care Surg. 2014;76:358\u201365. https:\/\/doi.org\/10.1097\/TA.0b013e3182a9cd31.","journal-title":"J Trauma Acute Care Surg"},{"key":"5147_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ijc.23875","volume":"124","author":"S Eaker","year":"2009","unstructured":"Eaker S, Halmin M, Bellocco R, et al. Social differences in breast cancer survival in relation to patient management within a national health care system (Sweden). Int J Cancer. 2009;124:180\u20137. https:\/\/doi.org\/10.1002\/ijc.23875.","journal-title":"Int J Cancer"},{"key":"5147_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/bjc.2012.186","volume":"107","author":"N Cavalli-Bj\u00f6rkman","year":"2012","unstructured":"Cavalli-Bj\u00f6rkman N, Qvortrup C, Sebj\u00f8rnsen S, et al. Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone. Br J Cancer. 2012;107:189\u201394. https:\/\/doi.org\/10.1038\/bjc.2012.186.","journal-title":"Br J Cancer"},{"key":"5147_CR37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ejvs.2015.07.006","volume":"50","author":"KHJ Ultee","year":"2015","unstructured":"Ultee KHJ, Bastos Gon\u00e7alves F, Hoeks SE, et al. Low socioeconomic status is an independent risk factor for survival after abdominal aortic aneurysm repair and open surgery for peripheral artery disease. Eur J Vasc Endovasc Surg. 2015;50:615\u201322. https:\/\/doi.org\/10.1016\/j.ejvs.2015.07.006.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"5147_CR38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.5114\/ait.2021.108084","volume":"53","author":"VP van Heerden","year":"2021","unstructured":"van Heerden VP, Beil M, Guidet B, et al. A new multi-national network studying very old intensive care patients (VIPs). Anaesthesiol Intensiv Ther. 2021;53:290\u20135. https:\/\/doi.org\/10.5114\/ait.2021.108084.","journal-title":"Anaesthesiol Intensiv Ther"},{"key":"5147_CR39","unstructured":"SIR|Utdataportalen. https:\/\/portal.icuregswe.org\/utdata\/sv\/report\/mort_mortalitet-iva. Accessed 31 Jul 2024."},{"key":"5147_CR40","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1097\/CCM.0000000000002098","volume":"45","author":"FH Andersen","year":"2017","unstructured":"Andersen FH, Flaatten H, Klepstad P, et al. Long-term outcomes after ICU admission triage in octogenarians. Crit Care Med. 2017;45:e363\u201371. https:\/\/doi.org\/10.1097\/CCM.0000000000002098.","journal-title":"Crit Care Med"},{"key":"5147_CR41","unstructured":"European Medicines Agency (EMEA). Guideline on Clinical Investigation of Medicinal Products for the Treatment of Sepsis. Committee for medicinal products for human use (CHMP). 2006. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-investigation-medicinal-products-treatment-sepsis_en.pdf. Accessed 29 May 2024."},{"key":"5147_CR42","unstructured":"European Medicines Agency (EMEA). Guideline on Clinical Investigation of Medicinal Products for the Treatment of Acute Respiratory Distress Syndrome. Committee for medicinal products for human use (CHMP). 2006. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-investigation-medicinal-products-treatment-patients-acute-respiratory-distress-syndrome_en.pdf. Accessed 29 May 2024."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05147-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-024-05147-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05147-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T13:06:05Z","timestamp":1731589565000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-024-05147-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5147"],"URL":"https:\/\/doi.org\/10.1186\/s13054-024-05147-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5014175\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"1 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"368"}}